Tectonic Therapeutics TECX Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Tectonic Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Tectonic Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tectonic Therapeutics's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tectonic Therapeutics's accrued expenses?
- Tectonic Therapeutics (TECX) reported accrued expenses of $8.97M in Q1 2026.
- How has Tectonic Therapeutics's accrued expenses changed year-over-year?
- Tectonic Therapeutics's accrued expenses increased by 82.9% year-over-year, from $4.91M to $8.97M.
- What is the long-term trend for Tectonic Therapeutics's accrued expenses?
- Over 5 years (2020 to 2025), Tectonic Therapeutics's accrued expenses has grown at a -11.7% compound annual growth rate (CAGR), from $13.69M to $7.34M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.